Target intelligence / Profile preview

Biogenesis of lysosomal organelles complex 2 subunit 3 (HPS6)

Target
HPS6
Molecular classification
Other (Organelle biogenesis complex component), Carrier protein, Peripheral membrane protein, Non-enzymatic multi-subunit complex member (BLOC-2 complex)
01

Overview

Biogenesis of lysosomal organelles complex 2 subunit 3 (HPS6) is a critical peripheral membrane protein and a subunit of the BLOC-2 complex, which includes HPS3 and HPS5. This complex mediates intracellular trafficking and sorting of proteins to lysosome-related organelles such as melanosomes (pigment-containing organelles), platelet dense granules, and Weibel–Palade bodies (in endothelial cells). HPS6 acts as a cargo adapter for the dynein-dynactin motor complex, facilitating retrograde transport of lysosomes, and is essential for lysosome maturation and function. Mutations in HPS6 disrupt the function of BLOC-2, impairing the proper delivery of melanogenic enzymes (like tyrosinase and TYRP1) to melanosomes, leading to defective melanosome maturation, hypopigmentation, and bleeding diathesis characteristic of Hermansky-Pudlak syndrome type 6. HPS6 is encoded by a single-exon gene expressed ubiquitously and does not contain known functional domains found in classic receptors or enzymes. There are currently no described therapeutic drugs interacting directly with HPS6, nor is it a recognized molecular drug target.

Other names
BLOC-2 complex member HPS6Hermansky-Pudlak syndrome 6 proteinRuby-eye protein homologFLJ22501BLOC2S3RuHermansky-Pudlak syndrome-6 proteinHPS6 biogenesis of lysosomal organelles complex 2 subunit 3
02

Mechanism of action

Not applicable. HPS6 is not a known drug target, no mechanism of drug action reported.

03

Biological functions

Organelle biogenesis (lysosome-related organelles, melanosomes, platelet dense granules, Weibel–Palade bodies)Intracellular trafficking of proteins and cargoCargo adaptor for retrograde lysosome transport (dynein-dynactin complex)
04

Disease associations

Hermansky-Pudlak syndrome type 6 (autosomal recessive albinism and bleeding diathesis)Platelet dysfunction (deficient dense granule formation, bleeding tendency)Hypopigmentation (defective melanosome maturation)
05

Safety considerations

Not applicable for therapeutic targeting. However, deficiency/mutation causes bleeding disorders and oculocutaneous albinism (Hermansky-Pudlak syndrome type 6)
06

Biomarkers

Mutational analysis of HPS6 gene (diagnosis of Hermansky-Pudlak syndrome type 6, patient selection)Immunofluorescent microscopy of melanocyte melanosomal protein localization (TYR, TYRP1) in cell studies for diagnostic confirmation

Beyond the preview

Go deeper on Biogenesis of lysosomal organelles complex 2 subunit 3 (HPS6).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Biogenesis of lysosomal organelles complex 2 subunit 3 (HPS6).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call